Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Prognostic value of a 92-probe signature in breast cancer.

Prognostic value of a 92-probe signature in breast cancer. Oncotarget. 2015 Jun 20; 6(17):15662-80.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.